This website is intended for adults purchasing products solely for lawful laboratory and research purposes.
BPC-157 is an experimental peptide studied mainly in tissue-repair, tendon, ligament, muscle, gastrointestinal and wound-healing models. Most of the published evidence remains preclinical rather than large, controlled human trials.
A reliable human adverse-effect profile has not been established. A 2025 pilot reported no adverse effects in only two healthy adults receiving intravenous BPC-157, which is far too small to establish safety. Manufacturing quality, contamination, immune reactions and unknown long-term effects remain meaningful uncertainties.
Animal studies repeatedly report faster healing in tendon, muscle, ligament and bone injury models. A recent review identified one very small uncontrolled human knee-pain series in which 7 of 12 participants reported prolonged pain relief; the study design is too weak to establish efficacy.
Additional commentary from Dr. Dean Jones, DC. This video is embedded for context and education; WILGO does not control or independently verify claims made in third-party videos.
Video hosted by YouTube. Opening or playing it may be subject to YouTube's privacy terms.
Follow the tracked WILGO product link to see current inventory, exact product specifications and checkout pricing.